Literature DB >> 22837584

Modulation of Ligand Fluorescence by the Pt(II)/Pt(IV) Redox Couple.

Justin J Wilson1, Stephen J Lippard.   

Abstract

The dangling carboxylic acid moiety of the known platinum(II) complex, [Pt(edma)Cl(2)] (edma = ethylenediaminemonoacetic acid), was functionalized via amide coupling chemistry with benzyl amine and dansyl ethylenediamine to afford the derivatives [Pt(edBz)Cl(2)] (1) and [Pt(edDs)Cl(2)] (2). Subsequent oxidation of these platinum(II) complexes with iodobenzene dichloride in DMF yielded the respective platinum(IV) analogues, [Pt(edBz)Cl(4)] (3) and [Pt(edDs)Cl(4)] (4). All four platinum complexes were characterized by multinuclear NMR spectroscopy, IR spectroscopy, electrospray ionization mass spectrometry, and elemental analysis. In addition, compounds 1 and 3 were structurally characterized by X-ray crystallography. The photophysical properties of the compounds bearing the fluorescent dansyl moiety, 2 and 4, were evaluated. The emission quantum yields of 2 and 4 in DMF are 27% and 1.6%, respectively. This large difference in emission efficiency indicates that the platinum(IV) center in 4 is more effective at quenching the dansyl-based fluorescence than the platinum(II) center in 2. Time-dependent density functional theory calculations indicate that 4 has several low-lying singlet excited states that energetically lie below the primary radiation-accessible excited state of the dansyl fluorophore. These low-energy excited states may offer non-radiative decay pathways that lower the overall emission quantum yield. Treatment of 4 with biologically relevant reducing agents in pH 7.4 phosphate-buffered saline induces a 6.3-fold increase in emission intensity. These results demonstrate that 4 and future derivatives thereof may be useful for imaging the reduction of platinum(IV) complexes in living systems, chemistry of importance for future platinum-based anticancer drug strategies.

Entities:  

Year:  2012        PMID: 22837584      PMCID: PMC3403686          DOI: 10.1016/j.ica.2011.12.034

Source DB:  PubMed          Journal:  Inorganica Chim Acta        ISSN: 0020-1693            Impact factor:   2.545


  26 in total

1.  Automated parallel solid-phase synthesis and anticancer screening of a library of peptide-tethered platinum(II) complexes.

Authors:  Marc S Robillard; Marina Bacac; Hans van den Elst; Anna Flamigni; Gijs A van der Marel; Jacques H van Boom; Jan Reedijk
Journal:  J Comb Chem       Date:  2003 Nov-Dec

2.  XANES determination of the platinum oxidation state distribution in cancer cells treated with platinum(IV) anticancer agents.

Authors:  Matthew D Hall; Garry J Foran; Mei Zhang; Philip J Beale; Trevor W Hambley
Journal:  J Am Chem Soc       Date:  2003-06-25       Impact factor: 15.419

3.  Synthesis, characterization, and photophysical properties of three platinum(II) complexes bearing fluorescent analogues of the Di-2-pyridylmethane ligand.

Authors:  Justin J Wilson; Juliana Fedoce Lopes; Stephen J Lippard
Journal:  Inorg Chem       Date:  2010-06-07       Impact factor: 5.165

Review 4.  195Pt NMR--theory and application.

Authors:  Brett M Still; P G Anil Kumar; Janice R Aldrich-Wright; William S Price
Journal:  Chem Soc Rev       Date:  2006-11-17       Impact factor: 54.564

Review 5.  Bright ideas for chemical biology.

Authors:  Luke D Lavis; Ronald T Raines
Journal:  ACS Chem Biol       Date:  2008-03-20       Impact factor: 5.100

6.  Investigations using fluorescent ligands to monitor platinum(IV) reduction and platinum(II) reactions in cancer cells.

Authors:  Elizabeth J New; Ran Duan; Jenny Z Zhang; Trevor W Hambley
Journal:  Dalton Trans       Date:  2009-03-06       Impact factor: 4.390

7.  Non-traditional platinum compounds for improved accumulation, oral bioavailability, and tumor targeting.

Authors:  Katherine S Lovejoy; Stephen J Lippard
Journal:  Dalton Trans       Date:  2009-10-01       Impact factor: 4.390

8.  New insights in the cellular processing of platinum antitumor compounds, using fluorophore-labeled platinum complexes and digital fluorescence microscopy.

Authors:  C Molenaar; J M Teuben; R J Heetebrij; H J Tanke; J Reedijk
Journal:  J Biol Inorg Chem       Date:  2000-10       Impact factor: 3.358

Review 9.  The resurgence of platinum-based cancer chemotherapy.

Authors:  Lloyd Kelland
Journal:  Nat Rev Cancer       Date:  2007-07-12       Impact factor: 60.716

10.  A fluorescent polymeric heparin sensor.

Authors:  Wei Sun; Heinz Bandmann; Thomas Schrader
Journal:  Chemistry       Date:  2007       Impact factor: 5.236

View more
  11 in total

1.  Oxidative halogenation of cisplatin and carboplatin: synthesis, spectroscopy, and crystal and molecular structures of Pt(IV) prodrugs.

Authors:  Timothy C Johnstone; Sarah M Alexander; Justin J Wilson; Stephen J Lippard
Journal:  Dalton Trans       Date:  2015-01-07       Impact factor: 4.390

Review 2.  Synthetic methods for the preparation of platinum anticancer complexes.

Authors:  Justin J Wilson; Stephen J Lippard
Journal:  Chem Rev       Date:  2013-11-27       Impact factor: 60.622

3.  Synthesis and characterization of Pt(IV) fluorescein conjugates to investigate Pt(IV) intracellular transformations.

Authors:  Ying Song; Kogularamanan Suntharalingam; Jessica S Yeung; Maksim Royzen; Stephen J Lippard
Journal:  Bioconjug Chem       Date:  2013-09-10       Impact factor: 4.774

4.  Oxidative Reactivity and Cytotoxic Properties of a Platinum(II) Complex Prepared by Outer-Sphere Amide Bond Coupling.

Authors:  Justin J Wilson; Stephen J Lippard
Journal:  Polyhedron       Date:  2013-07-13       Impact factor: 3.052

5.  NanoSIMS combined with fluorescence microscopy as a tool for subcellular imaging of isotopically labeled platinum-based anticancer drugs.

Authors:  Anton A Legin; Arno Schintlmeister; Michael A Jakupec; Mathea S Galanski; Irene Lichtscheidl; Michael Wagner; Bernhard K Keppler
Journal:  Chem Sci       Date:  2014-06-06       Impact factor: 9.969

Review 6.  Nanoscale drug delivery platforms overcome platinum-based resistance in cancer cells due to abnormal membrane protein trafficking.

Authors:  Xue Xue; Matthew D Hall; Qiang Zhang; Paul C Wang; Michael M Gottesman; Xing-Jie Liang
Journal:  ACS Nano       Date:  2013-12-10       Impact factor: 15.881

7.  NanoSIMS multi-element imaging reveals internalisation and nucleolar targeting for a highly-charged polynuclear platinum compound.

Authors:  Louise E Wedlock; Matt R Kilburn; Rong Liu; Jeremy A Shaw; Susan J Berners-Price; Nicholas P Farrell
Journal:  Chem Commun (Camb)       Date:  2013-08-11       Impact factor: 6.222

8.  Cell-permeable lanthanide-platinum(IV) anti-cancer prodrugs.

Authors:  Kezi Yao; Gogulan Karunanithy; Alison Howarth; Philip Holdship; Amber L Thompson; Kirsten E Christensen; Andrew J Baldwin; Stephen Faulkner; Nicola J Farrer
Journal:  Dalton Trans       Date:  2021-06-29       Impact factor: 4.390

9.  Pt(IV) prodrugs designed to bind non-covalently to human serum albumin for drug delivery.

Authors:  Yao-Rong Zheng; Kogularamanan Suntharalingam; Timothy C Johnstone; Hyunsuk Yoo; Wei Lin; Jamar G Brooks; Stephen J Lippard
Journal:  J Am Chem Soc       Date:  2014-06-06       Impact factor: 15.419

10.  Gd(iii)-Pt(iv) theranostic contrast agents for tandem MR imaging and chemotherapy.

Authors:  Casey J Adams; Thomas J Meade
Journal:  Chem Sci       Date:  2020-01-28       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.